American International Group, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.21 - $39.48 $707,704 - $1.03 Million	26,009 Added 13.39%	220,217 $6.3 Million
Q4 2023 Feb 13, 2024	SELL	$21.2 - $31.03 $135,913 - $198,933	-6,411 Reduced 3.2%	194,208 $5.94 Million
Q3 2023 Nov 13, 2023	SELL	$26.2 - $36.08 $236,140 - $325,189	-9,013 Reduced 4.3%	200,619 $5.39 Million
Q2 2023 Aug 04, 2023	SELL	$25.16 - $41.38 $152,922 - $251,507	-6,078 Reduced 2.82%	209,632 $7.48 Million
Q1 2023 May 12, 2023	BUY	$23.68 - $38.51 $77,054 - $125,311	3,254 Added 1.53%	215,710 $5.48 Million
Q4 2022 Feb 10, 2023	SELL	$28.0 - $40.56 $65,464 - $94,829	-2,338 Reduced 1.09%	212,456 $8.62 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $206,669 - $336,962	-6,975 Reduced 3.15%	214,794 $7.1 Million
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $188,193 - $342,730	-6,772 Reduced 2.96%	221,769 $7.81 Million
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $20,681 - $36,524	-522 Reduced 0.23%	228,541 $10.5 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $279,645 - $397,203	-4,814 Reduced 2.06%	229,063 $15.2 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $380,812 - $554,194	-6,523 Reduced 2.71%	233,877 $14.6 Million
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $539,275 - $783,706	-8,677 Reduced 3.48%	240,400 $19.9 Million
Q1 2021 May 07, 2021	BUY	$61.35 - $90.47 $229,571 - $338,538	3,742 Added 1.53%	249,077 $16.5 Million
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $37,334 - $72,735	-852 Reduced 0.35%	245,335 $18.8 Million
Q3 2020 Nov 04, 2020	SELL	$33.21 - $51.27 $133,637 - $206,310	-4,024 Reduced 1.61%	246,187 $10.6 Million
Q2 2020 Aug 12, 2020	SELL	$26.12 - $43.27 $69,009 - $114,319	-2,642 Reduced 1.04%	250,211 $10.8 Million
Q1 2020 May 04, 2020	BUY	$20.56 - $63.12 $56,622 - $173,832	2,754 Added 1.1%	252,853 $7.28 Million
Q4 2019 Feb 05, 2020	BUY	$28.14 - $73.01 $5.08 Million - $13.2 Million	180,656 Added 260.15%	250,099 $15.9 Million
Q3 2019 Nov 08, 2019	SELL	$26.26 - $34.86 $19,169 - $25,447	-730 Reduced 1.04%	69,443 $1.96 Million
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $182,404 - $301,601	10,465 Added 17.53%	70,173 $1.86 Million
Q1 2019 May 06, 2019	BUY	$12.05 - $20.18 $28,956 - $48,492	2,403 Added 4.19%	59,708 $1.1 Million
Q4 2018 Feb 13, 2019	SELL	$10.74 - $19.7 $4,725 - $8,668	-440 Reduced 0.76%	57,305 $712,000
Q3 2018 Nov 09, 2018	BUY	$14.0 - $20.3 $14,560 - $21,112	1,040 Added 1.83%	57,745 $1.11 Million
Q2 2018 Aug 08, 2018	BUY	$6.37 - $14.02 $361,210 - $795,004	56,705 New	56,705 $771,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

92.3M

Call Options Held

1.33M

Put Options Held

549K

Black Rock Inc. New York, NY

15.7M
Shares

$308 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

12.2M
Shares

$240 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

8.89M
Shares

$175 Million
3.15% of portfolio
State Street Corp Boston, MA

5.84M
Shares

$115 Million
0.01% of portfolio
Slate Path Capital LP New York, NY

4.14M
Shares

$81.4 Million
2.11% of portfolio

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account